Alcohol consumption in the general population is associated with structural changes in multiple organ systems

  1. Evangelos Evangelou
  2. Hideaki Suzuki
  3. Wenjia Bai
  4. Raha Pazoki
  5. He Gao
  6. Paul M Matthews MD, PhD
  7. Paul Elliott  Is a corresponding author
  1. University of Ioannina, Greece
  2. Imperial College London, United Kingdom
  3. Brunel University London, United Kingdom

Abstract

Background: Excessive alcohol consumption is associated with damage to various organs, but its multi-organ effects have not been characterised across the usual range of alcohol drinking in a large general population sample.

Methods: We assessed global effect sizes of alcohol consumption on quantitative magnetic resonance imaging phenotypic measures of the brain, heart, aorta and liver of UK-Biobank participants who reported drinking alcohol.

Results: We found a monotonic association of higher alcohol consumption with lower normalised brain volume across the range of alcohol intakes (–1.7´10-3±0.76´10-3 per doubling of alcohol consumption, P=3.0´10-14). Alcohol consumption also was associated directly with measures of left ventricular mass index and left ventricular and atrial volume indices. Liver fat increased by a mean of 0.15% per doubling of alcohol consumption.

Conclusions: Our results imply that there is not a 'safe threshold' below which there are no toxic effects of alcohol. Current public health guidelines concerning alcohol consumption may need to be revisited.

Funding: See acknowledgements

Data availability

For this project, UK Biobank has granted access to our team through approved applications with ID #13375 and #18545. Individual-level data cannot be shared with researchers who are not registered as collaborators (https://www.ukbiobank.ac.uk/enable-your-research/manage-your-project). Guidance on how to apply for the various types of UK Biobank can be found in the following link https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access.

Article and author information

Author details

  1. Evangelos Evangelou

    Department of Hygiene and Epidemiology, University of Ioannina, Ioannina, Greece
    Competing interests
    Evangelos Evangelou, E.E. acknowledges consultancy fees from OpenDNA.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5488-2999
  2. Hideaki Suzuki

    Department of Brain Sciences, Imperial College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  3. Wenjia Bai

    Department of Brain Sciences, Imperial College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  4. Raha Pazoki

    Department of Life Sciences, Brunel University London, London, United Kingdom
    Competing interests
    No competing interests declared.
  5. He Gao

    School of Public Health, Imperial College London, London, United Kingdom
    Competing interests
    No competing interests declared.
  6. Paul M Matthews MD, PhD

    Brain Sciences, Imperial College London, London, United Kingdom
    Competing interests
    Paul M Matthews MD, PhD, acknowledges consultancy fees from Roche, Adelphi Communications, Celgene and Biogen. He has received honoraria or speakers' honoraria from Novartis, Biogen, Medscape, Adelphi Communications and Roche and has received research or educational funds from Biogen, Novartis, GlaxoSmithKline and Nodthera. He is a member of the Scientific Advisory Board to the Board of Ipsen Pharmaceuticals..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1619-8328
  7. Paul Elliott

    School of Public Health, Imperial College London, London, United Kingdom
    For correspondence
    p.elliott@imperial.ac.uk
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7511-5684

Funding

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Edward D Janus, University of Melbourne, Australia

Ethics

Human subjects: In UK Biobank, ethical approval for data collection was received from the North-West Multi-centre Research Ethics Committee (REC reference: 11/NW/0382) and the research was carried out in accordance with the Declaration of Helsinki of the World Medical Association. No additional ethical approval was required for the analyses of the data.

Version history

  1. Received: December 1, 2020
  2. Accepted: June 1, 2021
  3. Accepted Manuscript published: June 1, 2021 (version 1)
  4. Version of Record published: June 10, 2021 (version 2)

Copyright

© 2021, Evangelou et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,179
    views
  • 223
    downloads
  • 15
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Evangelos Evangelou
  2. Hideaki Suzuki
  3. Wenjia Bai
  4. Raha Pazoki
  5. He Gao
  6. Paul M Matthews MD, PhD
  7. Paul Elliott
(2021)
Alcohol consumption in the general population is associated with structural changes in multiple organ systems
eLife 10:e65325.
https://doi.org/10.7554/eLife.65325

Share this article

https://doi.org/10.7554/eLife.65325

Further reading

    1. Epidemiology and Global Health
    Yuchen Zhang, Yitang Sun ... Kaixiong Ye
    Research Article

    Background:

    Circulating omega-3 and omega-6 polyunsaturated fatty acids (PUFAs) have been associated with various chronic diseases and mortality, but results are conflicting. Few studies examined the role of omega-6/omega-3 ratio in mortality.

    Methods:

    We investigated plasma omega-3 and omega-6 PUFAs and their ratio in relation to all-cause and cause-specific mortality in a large prospective cohort, the UK Biobank. Of 85,425 participants who had complete information on circulating PUFAs, 6461 died during follow-up, including 2794 from cancer and 1668 from cardiovascular disease (CVD). Associations were estimated by multivariable Cox proportional hazards regression with adjustment for relevant risk factors.

    Results:

    Risk for all three mortality outcomes increased as the ratio of omega-6/omega-3 PUFAs increased (all Ptrend <0.05). Comparing the highest to the lowest quintiles, individuals had 26% (95% CI, 15–38%) higher total mortality, 14% (95% CI, 0–31%) higher cancer mortality, and 31% (95% CI, 10–55%) higher CVD mortality. Moreover, omega-3 and omega-6 PUFAs in plasma were all inversely associated with all-cause, cancer, and CVD mortality, with omega-3 showing stronger effects.

    Conclusions:

    Using a population-based cohort in UK Biobank, our study revealed a strong association between the ratio of circulating omega-6/omega-3 PUFAs and the risk of all-cause, cancer, and CVD mortality.

    Funding:

    Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institute of Health under the award number R35GM143060 (KY). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

    1. Ecology
    2. Epidemiology and Global Health
    Aleksandra Kovacevic, David RM Smith ... Lulla Opatowski
    Research Article

    Non-pharmaceutical interventions implemented to block SARS-CoV-2 transmission in early 2020 led to global reductions in the incidence of invasive pneumococcal disease (IPD). By contrast, most European countries reported an increase in antibiotic resistance among invasive Streptococcus pneumoniae isolates from 2019 to 2020, while an increasing number of studies reported stable pneumococcal carriage prevalence over the same period. To disentangle the impacts of the COVID-19 pandemic on pneumococcal epidemiology in the community setting, we propose a mathematical model formalizing simultaneous transmission of SARS-CoV-2 and antibiotic-sensitive and -resistant strains of S. pneumoniae. To test hypotheses underlying these trends five mechanisms were built into the model and examined: (1) a population-wide reduction of antibiotic prescriptions in the community, (2) lockdown effect on pneumococcal transmission, (3) a reduced risk of developing an IPD due to the absence of common respiratory viruses, (4) community azithromycin use in COVID-19 infected individuals, (5) and a longer carriage duration of antibiotic-resistant pneumococcal strains. Among 31 possible pandemic scenarios involving mechanisms individually or in combination, model simulations surprisingly identified only two scenarios that reproduced the reported trends in the general population. They included factors (1), (3), and (4). These scenarios replicated a nearly 50% reduction in annual IPD, and an increase in antibiotic resistance from 20% to 22%, all while maintaining a relatively stable pneumococcal carriage. Exploring further, higher SARS-CoV-2 R0 values and synergistic within-host virus-bacteria interaction mechanisms could have additionally contributed to the observed antibiotic resistance increase. Our work demonstrates the utility of the mathematical modeling approach in unraveling the complex effects of the COVID-19 pandemic responses on AMR dynamics.